Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on October 7, 2025. The filing discloses the appointment of a new Chief Financial Officer and details the associated employment agreement.
Key Financial Metrics
This filing does not contain operational financial results such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The financial data presented relates exclusively to executive compensation.
- Base Salary: $725,000 annualized.
- Target Annual Cash Bonus: 85% of Base Salary (commencing 2026).
- One-Time Cash Award: $460,000 (payable by March 31, 2026).
- Initial Equity Grant: Restricted Stock Units (RSUs) with a grant date fair value of $1,200,000.
- 2026 Equity Grant Minimum: Annual grant date fair value of no less than $2,900,000.
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Todd Young appointed as Chief Financial Officer, effective October 27, 2025.
- Transition: Timothy Sides will cease serving as Interim CFO upon Mr. Young's start date and resume his role as Senior Vice President, Operations Finance.
- Background: Mr. Young joins from Elanco Animal Health, where he served as Executive Vice President and CFO since 2018.
Outlook, Risks, and Contingencies
The filing outlines significant severance contingencies in the event of a "Qualifying Termination" (termination without Cause or resignation for Good Reason):
- Severance Pay: 12 months of Base Salary.
- Accelerated Vesting: All time-based equity awards will be deemed fully vested.
- Performance Equity: Performance-based awards remain outstanding and eligible to vest based on actual achievement.
- Other Benefits: Includes prorated bonus, payment of prior year bonus and one-time cash award, COBRA premium reimbursement, and relocation expense reimbursement.
Investor Verification Checklist
- Verify the effective date of Todd Young's appointment (October 27, 2025) and the transition of Timothy Sides.
- Review the attached Employment Agreement (Exhibit 10) for specific definitions of "Cause" and "Good Reason."
- Confirm the vesting schedule and performance criteria for the $1.2 million initial RSU grant and future annual equity awards.
- Assess the impact of the one-time $460,000 cash award and future compensation on the company's operating expenses.